SKP2 and prostate neoplasm: Worthy of note, Skp2 ablation with concurrent enhanced levels of Foxa1 in Ptenpc−/−; Trp53pc−/−; Skp2−/− mice resulted in decreased tumor burden by suppressing prostate tumor proliferation.